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Clarence Agress Pioneers Experimental Thrombolysis of the Coronary
Artery in 1952
EDWARD SHAPIRO, MD, FACC
L().~ AIINele.\" . Californiu
In 1952, Clarence Agress performed an experiment on
dogs to demonstrate his idea that a thrombus in a coro-
nary artery could be dissolved without harm to the myo-
The year 1952 marked the beginning of modern techniques
for lysing thrombi in acute myocard ial infarction. John son
and Tillett ( I) dissolved intra vascular thrombi in rabbit ear s
with streptokinase and Innerfield et al. (2) showed in dogs
that trypsin could lyse preformed clots. In September 1952
Agress et al. (3) publ ished their first innovative paper , " In-
travenous Trypsin in Experimental Myocard ial Infarct ion ."
A more complete report followed in 1954 (4). The se ex-
perim ents. althou gh primiti ve, should be recognized as the
first effort to show that thrombi in the coronary arter ies
could be lysed without injury to the myocardium.
The method used , injecting lyophili zed fibrin clot s in the
closed chest dog , was made possible by a special doubl e
lumen catheter (5). This catheter. inserted through the left
internal carotid artery, enabl ed the direct injection of the
preformed clots into the coronary ostia to the point of per-
sistent electrocardiographic (ECG ) evidence of myocardial
infarction .
Of the 29 dogs that sustained myocardial infarction . 16
receiv ed one to six injections of intravenous trypsin over a
period of 8 days, and 13 served as controls. The dogs then
underwent autopsy to examine the clots in the coronary
arteries . Evans blue dye was injected into the coro nary ar-
teries and the occluded areas of myocardium were photo-
graphed in color to facilitate estimation of the extent of
infarct ion. These areas were further studied by micro scopic
sections; comparable degree s of infarct ion were present in
the treated and control dogs.
Agress et al. found that embolizing fibrin particles into
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the coro nary arteries of closed ches t dogs produced the same
changes as those induced by coro nary ligation : extensive
myocardial infarction as revealed by pallor , cyanosis. bal-
loon ing and cardiac dilation . Microscopic section of the
myocardium of contro l dogs showe d complete coro nary
thrombosis by fibrin particles and host thrombus in all but
one . The trypsin-tre ated dogs showed no new host thrombu s
around the fibrin particl es as indicated by coro nary irrigation
and histologic study . Recanal ization by enzymatic digestion
of the host thrombi occ urred only in the trypsin-t reated
animals . None of the treated dogs presented any adverse
effect of the infusion of trypsin.
Infarction produced by mult iple injec tions of fibrin em-
boli is not the same as co ronary thromb osis in human s. Onl y
the newly generated host thromb i aro und the fibrin clots
were lysed. Yet this same difficulty exists today and ac-
counts for the imperative administration of thrombolytic
agents within a short time after the onset of myocardial
infarction . Despite these caveats. the novel idea of these
early experiments and the impetus they gave to subsequent
research deser ve remembrance in todays era of effective
thrombolysis .
Prophet ically . Agress et al. wro te in 1954: " It is felt that
our experiments dem onstrated that a pro teo lytic enzyme can
significantly aid the dissoluti on of coro nary arterial throm-
bosis without further damage to the infarc ted myocardium.
thus greatly strengthening the hope that an effective agent
may be found for human use ."
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